Department of Prosthodontics and Implantology, Sree Siddharth Dental College, Sree Siddharth Academy of Higher Education, Tumkur, Karnataka, India.
Department of Prosthodontics, Sardar Patel Postgraduate Institute of Dental and Medical Sciences, Lucknow, Uttar Pradesh, India.
J Contemp Dent Pract. 2020 Aug 1;21(8):880-883.
To assess the survival rate of short dental implants in medically compromised patients.
This follow-up study was conducted on 342 medically compromised patients of both genders (580 dental implants). The failure rate of dental implants was assessed.
There were 142 diabetes mellitus patients with 254 dental implants, 108 patients with hypertension with 190 dental implants, 26 patients with mental disabilities with 40 dental implants, 20 oral cancer patients with 36 dental implants, and 46 osteomyelitis subjects with 60 dental implants. There were 60 (10.5%) short dental implant (SDI) failures of which a maximum of 25 (22.7%) were seen with 4 mm diameter. Maximum failure was seen with osteomyelitis patients 8 (13.3%) followed by diabetes mellitus 32 (12.5%). Out of 270 dental implants in 130 control patients, implant failure was seen in 11 (4.07%). There was a significant ( < 0.05) bone loss on follow-up at 6 months, 1 year, and 2 years.
Medically compromised patients are more prone to dental implant failure as compared to healthy subjects.
Since medically compromised patients are prone for implant failure, careful selection of cases is necessary.
评估患有医学并发症的患者中短种植体的存活率。
本随访研究纳入了 342 名患有医学并发症的男女患者（580 枚种植体）。评估了种植体的失败率。
有 142 名糖尿病患者（254 枚种植体），108 名高血压患者（190 枚种植体），26 名精神残疾患者（40 枚种植体），20 名口腔癌患者（36 枚种植体）和 46 名骨髓炎患者（60 枚种植体）。有 60 枚（10.5%）短种植体（SDI）失败，其中最大的 25 枚（22.7%）直径为 4 毫米。骨髓炎患者的失败率最高，为 8 例（13.3%），其次是糖尿病患者 32 例（12.5%）。在 130 名对照患者的 270 枚种植体中，有 11 枚（4.07%）出现种植体失败。在 6 个月、1 年和 2 年的随访中，有显著的（<0.05）骨量丢失。
与健康受试者相比，患有医学并发症的患者更容易发生种植体失败。
由于患有医学并发症的患者更容易发生种植体失败，因此有必要对病例进行仔细选择。
